Target based virtual screening by docking into automatically generated GPCR models.

Target based virtual screening (VS) combined with high-throughput measurements is an extremely useful tool to identify small molecule hits for proteins and in particular for G-protein coupled receptors (GPCRs). However, this is a quite difficult process for GPCRs due to the paucity of 3D structural information on these receptors. Therefore, the only possibility for target based VS is to build a structural model of the GPCR to be used for docking. However, GPCR model building is a very time consuming process, if the model should be able to explain all experimental findings and this investment is not always justified, if the model is only used for VS. Thus, a fully automated workflow is presented here, where a large number of GPCR models is built, and the best model is identified to be used for docking. The workflow leads to moderate enrichments with a very low effort. The inputs required are the sequence of the targeted GPCR, a reference ligand with experimental information and a database of small molecules to be used for docking. Manual intervention is recommended at various points, but it is strictly speaking not necessary.

[1]  K. Palczewski,et al.  Crystal Structure of Rhodopsin: A G‐Protein‐Coupled Receptor , 2002, Chembiochem : a European journal of chemical biology.

[2]  Charles Simon Bond,et al.  ALINE: a WYSIWYG protein-sequence alignment editor for publication-quality alignments. , 2009, Acta crystallographica. Section D, Biological crystallography.

[3]  Shay Bar-Haim,et al.  G protein-coupled receptors: in silico drug discovery in 3D. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[4]  Nagarajan Vaidehi,et al.  Agonist-induced conformational changes in bovine rhodopsin: insight into activation of G-protein-coupled receptors. , 2008, Journal of molecular biology.

[5]  Nagarajan Vaidehi,et al.  Computational mapping of the conformational transitions in agonist selective pathways of a G-protein coupled receptor. , 2010, Journal of the American Chemical Society.

[6]  Didier Rognan,et al.  Protein‐based virtual screening of chemical databases. II. Are homology models of g‐protein coupled receptors suitable targets? , 2002, Proteins.

[7]  Matthew P. Repasky,et al.  Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. , 2004, Journal of medicinal chemistry.

[8]  T. Klabunde,et al.  Structure-based drug discovery using GPCR homology modeling: successful virtual screening for antagonists of the alpha1A adrenergic receptor. , 2005, Journal of medicinal chemistry.

[9]  O. Civelli,et al.  Orphan GPCR research , 2008, British journal of pharmacology.

[10]  Jonathan A. Javitch,et al.  Structure of the Human Dopamine D3 Receptor in Complex with a D2/D3 Selective Antagonist , 2010, Science.

[11]  H. Senderowitz,et al.  G protein coupled receptors -in silico drug discovery and design. , 2010, Current topics in medicinal chemistry.

[12]  E. Kellenberger,et al.  Identification of nonpeptide CCR5 receptor agonists by structure-based virtual screening. , 2007, Journal of medicinal chemistry.

[13]  H. Schiöth,et al.  The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints. , 2003, Molecular pharmacology.

[14]  Arne Elofsson,et al.  Using multiple templates to improve quality of homology models in automated homology modeling , 2008, Protein science : a publication of the Protein Society.

[15]  Ian T. Crosby,et al.  Homology Modeling and Docking Evaluation of Aminergic G Protein-Coupled Receptors , 2010, J. Chem. Inf. Model..

[16]  Herbert Köppen.  Virtual screening - what does it give us? , 2009, Current opinion in drug discovery & development.

[17]  R. Abagyan,et al.  Structures of the CXCR4 Chemokine GPCR with Small-Molecule and Cyclic Peptide Antagonists , 2010, Science.

[18]  J. Lowe,et al.  The discovery of (2S,3S)-cis-2-(diphenylmethyl)-N-[(2-methoxyphenyl)methyl]-1- azabicyclo[2.2.2]-octan-3-amine as a novel, nonpeptide substance P antagonisst. , 1992, Journal of medicinal chemistry.

[19]  J. Ballesteros,et al.  [19] Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors , 1995 .

[20]  Andreas Evers,et al.  Sequence-derived three-dimensional pharmacophore models for G-protein-coupled receptors and their application in virtual screening. , 2009, Journal of medicinal chemistry.

[21]  Andreas Hildebrandt,et al.  Revisiting automated G-protein coupled receptor modeling: the benefit of additional template structures for a neurokinin-1 receptor model. , 2009, Journal of medicinal chemistry.

[22]  E. Jaeger,et al.  Comparison of automated docking programs as virtual screening tools. , 2005, Journal of Medicinal Chemistry.

[23]  T. Blundell,et al.  Comparative protein modelling by satisfaction of spatial restraints. , 1993, Journal of molecular biology.

[24]  Stefano Costanzi,et al.  Discovery of novel agonists and antagonists of the free fatty acid receptor 1 (FFAR1) using virtual screening. , 2008, Journal of medicinal chemistry.

[25]  A. Sali,et al.  Comparative protein structure modeling of genes and genomes. , 2000, Annual review of biophysics and biomolecular structure.

[26]  Yongbo Hu,et al.  Comparison of Several Molecular Docking Programs: Pose Prediction and Virtual Screening Accuracy , 2009, J. Chem. Inf. Model..

[27]  R. Stevens,et al.  High-Resolution Crystal Structure of an Engineered Human β2-Adrenergic G Protein–Coupled Receptor , 2007, Science.

[28]  Andreas Evers,et al.  Virtual screening of biogenic amine-binding G-protein coupled receptors: comparative evaluation of protein- and ligand-based virtual screening protocols. , 2005, Journal of medicinal chemistry.

[29]  M. Burghammer,et al.  Crystal structure of the human β2 adrenergic G-protein-coupled receptor , 2007, Nature.

[30]  O. Civelli,et al.  Orphan G protein‐coupled receptors: targets for new therapeutic interventions , 2004, Annals of medicine.

[31]  C. Langmead,et al.  Roof and Floor of the Muscarinic Binding Pocket: Variations in the Binding Modes of Orthosteric Ligands , 2007, Molecular Pharmacology.

[32]  G. Klebe,et al.  Successful virtual screening for a submicromolar antagonist of the neurokinin-1 receptor based on a ligand-supported homology model. , 2004, Journal of medicinal chemistry.

[33]  R. Stevens,et al.  Structure of an Agonist-Bound Human A2A Adenosine Receptor , 2011, Science.

[34]  A. Sali,et al.  Protein Structure Prediction and Structural Genomics , 2001, Science.

[35]  Wolfgang Guba,et al.  Focused library design in GPCR projects on the example of 5‐HT2c agonists: Comparison of structure‐based virtual screening with ligand‐based search methods , 2005, Proteins.

[36]  S. Rasmussen,et al.  Structure of a nanobody-stabilized active state of the β2 adrenoceptor , 2010, Nature.

[37]  Kenneth Lundstrom,et al.  Latest development in drug discovery on G protein-coupled receptors. , 2006, Current protein & peptide science.

[38]  Gebhard F. X. Schertler,et al.  Structure of a β1-adrenergic G-protein-coupled receptor , 2008, Nature.

[39]  G. V. Paolini,et al.  Empirical scoring functions: I. The development of a fast empirical scoring function to estimate the binding affinity of ligands in receptor complexes , 1997, J. Comput. Aided Mol. Des..

[40]  Junmei Wang,et al.  GPCR Structure-Based Virtual Screening Approach for CB2 Antagonist Search , 2007, J. Chem. Inf. Model..

[41]  Helgi B. Schiöth,et al.  Structural diversity of G protein-coupled receptors and significance for drug discovery , 2008, Nature Reviews Drug Discovery.

[42]  R. Stevens,et al.  The 2.6 Angstrom Crystal Structure of a Human A2A Adenosine Receptor Bound to an Antagonist , 2008, Science.

[43]  Didier Rognan,et al.  A chemogenomic analysis of the transmembrane binding cavity of human G‐protein‐coupled receptors , 2005, Proteins.

[44]  Alexander Pautsch,et al.  The Implication of the First Agonist Bound Activated GPCR X-ray Structure on GPCR in Silico Modeling. , 2011, ACS medicinal chemistry letters.

[45]  Richard D. Taylor,et al.  Improved protein–ligand docking using GOLD , 2003, Proteins.

[46]  D. Rognan,et al.  Protein-based virtual screening of chemical databases. 1. Evaluation of different docking/scoring combinations. , 2000, Journal of medicinal chemistry.

[47]  Christopher G. Tate,et al.  The structural basis for agonist and partial agonist action on a β1-adrenergic receptor , 2010, Nature.

[48]  M. Nowak,et al.  Homology modeling of the serotonin 5-HT1A receptor using automated docking of bioactive compounds with defined geometry. , 2006, Journal of medicinal chemistry.